Total Voting Rights

RNS Number : 8323G

Craneware plc

31 March 2022

 

Craneware plc

("Craneware" or the "Company" or the "Group")

Total Voting Rights

As at 31 March 2022, the Company's issued share capital consisted of 35,542,169 ordinary shares of 1 pence each ("Ordinary Shares") all with voting rights. No shares are currently held in treasury. The total number of voting rights in the Company as at 31 March 2022 is therefore 35,542,169.

The above figure (35,542,169 Ordinary Shares) may be used by shareholders as the denominator for the calculation by which they will determine if they are required to notify their interest in, or a change in their interest in, the Company.

For further information, please contact:

Craneware plc	[phone]
Keith Neilson, CEO
Craig Preston, CFO
Alma (Financial PR)	[phone]
Caroline Forde, Hilary Buchanan, Joe Pederzolli	[e-mail]
Peel Hunt (NOMAD and Joint Broker)	[phone]
Dan Webster, Andrew Clark
Investec Bank PLC (Joint Broker)	[phone]
Patrick Robb, Henry Reast, Sebastian Lawrence
Berenberg (Joint  Broker )	[phone]
Mark Whitmore, Richard Andrews, Alix Mecklenburg-Solodkoff

About Craneware

We at the Craneware Group of companies, including our latest additions Sentry Data Systems and Agilum Healthcare Intelligence, passionately believe we can impact healthcare profoundly by delivering the insights healthcare organizations need to also transform the business of healthcare. Our shared vision is to be the operational and financial partner for U.S. healthcare providers.

Our combined suite of applications and industry-leading team of experts help our customers contextualize operational, financial, and clinical data, providing insights that clearly demonstrate what great looks like. These value cycle insights deliver revenue integrity and 340B compliance, as well as margin and operational intelligence - something no other single partner can provide.

Together, approximately 40% of registered U.S. hospitals are now our customers, including more than 2,000 U.S hospitals and health systems and almost 10,000 clinics and affiliated retail pharmacies. Our customers are operating with a financial impact of nearly half a trillion dollars. We have data sets from customers covering more than 150 million unique patients encounters.

Learn more at www.craneware.com  

 

END

 

 

TVRBKDBKPBKDONN